ICD-10-CM Billable Code

E09.37

Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment

Clinical Classification Guidelines

7th Character Definition

One of the following 7th characters is to be assigned to code E09.37 to designate laterality of the disease:

Medical Intelligence & Overview

ICD-10 code E09.37 refers to a type of diabetes caused by medications or chemicals, linked with swelling in the eye's central area due to fluid buildup—a condition known as diabetic macular edema. This condition occurs as a complication of diabetes and may improve or resolve after appropriate treatment. The condition is important to recognize because it involves both blood sugar management and eye health, necessitating coordinated medical care.

Causes & Symptoms

Clinical Causes: Use of certain medications such as corticosteroids or other chemicals that impact blood sugar levels. Exposure to toxins or chemicals that interfere with insulin production or effectiveness. Pre-existing diabetes exacerbated by chemical or drug exposure. Other factors that impair pancreatic function or insulin activity leading to elevated blood glucose levels.

Key Symptoms: Blurred or decreased vision, especially in the central visual field. Swelling or thickening of the retina's macula, leading to visual impairment. Potential appearance of floaters or visual distortions. No noticeable symptoms in early stages; some individuals may experience mild visual changes initially. In some cases, there might be signs of overall high blood sugars such as increased thirst or frequent urination.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves comprehensive eye examinations, including optical coherence tomography (OCT) to detect macular edema, along with blood tests to evaluate blood glucose levels. Medical history is reviewed to identify possible medication or chemical exposures causing the condition. Ophthalmologists and endocrinologists work together to confirm the diagnosis and determine its cause. Imaging tests and detailed eye assessments help in determining the extent of eye involvement.

Treatment Protocols: Management includes addressing both blood sugar control and eye health. Treatment options may involve: - Adjusting or discontinuing the causative medication, under medical guidance. - Anti-diabetic medications to regulate blood glucose. - Injections of anti-VEGF agents or steroids into the eye to reduce swelling. - Laser therapy to seal leaking blood vessels in the retina. - Monitoring and regular eye check-ups to assess response to treatment. - Supportive measures like lifestyle modifications, including diet and exercise, to improve glucose management. The goal is to reduce macular edema and preserve or improve vision, while also managing the underlying cause.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E09.37 a billable ICD-10 code?
Yes, E09.37 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E09.37?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

resolved macular diabetic chemical mellitus treatment induced diabetes